Trial Profile
Levofloxacin for the prevention of bacterial infections in elderly non-small cell lung cancer patients undergoing chemotherapy with docetaxel + carboplatin
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Jan 2012
Price :
$35
*
At a glance
- Drugs Levofloxacin (Primary)
- Indications Bacterial infections
- Focus Therapeutic Use
- Acronyms APRONTA
- 05 Nov 2010 New trial record.